Block.one has granted quite a few progressive corporations which are growing options geared toward mitigating the affect of the coronavirus outbreak.
It has change into identified that Block.one is offering a $50,000 of an award to Genobank.io, as this blockchain firm is engaged on making an open-source app as a way to guarantee nameless and safe entry to COVID-19 testing. By way of its EOS VC Grants program and partnership with FinLab EOS VC, Block.one has additionally granted quite a few progressive corporations that selected to give attention to options associated to the coronavirus outbreak.
Block.One in Struggle with COVID-19 Influence
From biotech to employment, corporations utilizing Block.one’s EOSIO blockchain software program are all accelerating as a way to meet the brand new disputes arising from the disaster.
Block.one CEO Brendan Blumer explains:
“We’ve witnessed the expansion of an open supply group whose ardour and innovation have helped to establish and clear up vital enterprise issues in sectors starting from artwork to wellness. With the onset of pressing world points brought on by the coronavirus, it will be significant that we empower and assist the ways in which blockchain know-how is being utilized to supply options.”
Genobank.io Partnering with Telos Basis
DNA/RNA equipment supplier Genobank.io has partnered with the Telos Basis to develop an open-source app Agerona that may enable customers to securely supply low-cost COVID-19 testing.
Outcomes could be saved anonymously in a non-public repository in a distributed storage community. This information shall be ruled with teh assist of EOSIO-based blockchain platform Telos. All customers could have a risk to regulate their information, to share, edit and delete their outcomes with researchers utilizing well being privateness. The discharge of the app is scheduled for Might.
Daniel Uribe, Genobank.io CEO mentioned:
“As an EOS VC Grants recipient, we’re grateful to have the backing and assist of Block.one’s enterprise arm EOS VC in aiding our efforts to anonymize DNA/RNA check kits (together with coronavirus) whereas empowering sufferers and customers to determine if they need their anonymized information to be obtainable to the scientific group and assist management the unfold of the coronavirus and doubtlessly contribute to a remedy.”
Different Investments amid COVID-19
Then, the funds went to PUML Higher Well being. This can be a well being and wellness platform that permits corporations to reward members for engaging in wholesome exercise challenges. These challenges could embody day by day steps, gymnasium check-ins and health lessons. Whereas there are a lockdown and want for social distancing, the EOSIO-based platform has launched its LIVE STREAM service. So customers can observe exercises at dwelling.
Then, there are FinLab EOS VC investments Moonlighting and Innoplexus that are additionally addressing COVID-19 by adapting their platforms. On-demand freelance market Moonlighting has just lately mentioned to supply free entry to its database of 200,000 work-from-home job listings. The corporate’s platform runs on EOSIO powered by EOS and permits job-seekers to create profiles that will also be accessed by different freelance and gig marketplaces.
Within the meantime, Innoplexus introduced that it’ll share an open license by opening up its proprietary Ontosight® AI-based platform for drug discovery and improvement to medical researchers across the globe to assist and contribute to measures targeted on the containment of COVID-19.
Experienced creative professional focusing on financial and political analysis, editing daily newspapers and news sites, economical and political journalism, consulting, PR and Marketing. Teuta’s passion is to create new opportunities and bring people together.